ConductScience.org, home

Paper3348898

Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma.

Grenman R and 5 others. Arch Otolaryngol Head Neck Surg, 1988. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma. Papers, record 3348898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3348898

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma.
PubMed
Journal
Arch Otolaryngol Head Neck Surg
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2019-08-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grenman RR
2Burk DD
3Virolainen EE
4Wagner JGJ G
5Lichter ASA S
6Carey TET E

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Head and Neck NeoplasmsMajor topic
Cell Survival
Humans
Radiation Tolerance
Tumor Stem Cell Assay

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
00621PHS HHSUnited StatesPubMedPubMed
CA 28564NCI NIH HHSUnited StatesR01CA028564PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
41721007Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties.Nat Mater2026https://conductscience.org/library/papers/41721007PubMed
37202533Identification of acquired Notch3 dependency in metastatic Head and Neck Cancer.Commun Biol2023https://conductscience.org/library/papers/37202533PubMed
34320941Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.BMC Cancer2021https://conductscience.org/library/papers/34320941PubMed
26722027A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.Anticancer Res2016https://conductscience.org/library/papers/26722027PubMed
26417394Effect of ionizing radiation on the physical biology of head and neck squamous cell carcinoma cells.Cell Mol Bioeng2015https://conductscience.org/library/papers/26417394PubMed
25005846SIRT3 is a novel prognostic biomarker for esophageal squamous cell carcinoma.Med Oncol2014https://conductscience.org/library/papers/25005846PubMed
24348826Interaction of a CD44+ head and neck squamous cell carcinoma cell line with a stromal cell-derived factor-1-expressing supportive niche: An in vitro model.Oncol Lett2014https://conductscience.org/library/papers/24348826PubMed
21586315SIRT3 and cancer: tumor promoter or suppressor?Biochim Biophys Acta2011https://conductscience.org/library/papers/21586315PubMed
21472714Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.Cancer2011https://conductscience.org/library/papers/21472714PubMed
19047905DNA hypermethylation profiles in squamous cell carcinoma of the vulva.Int J Gynecol Pathol2009https://conductscience.org/library/papers/19047905PubMed
8123477Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.Br J Cancer1994https://conductscience.org/library/papers/8123477PubMed
7798295Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.J Cancer Res Clin Oncol1994https://conductscience.org/library/papers/7798295PubMed
1744166Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity.J Cancer Res Clin Oncol1991https://conductscience.org/library/papers/1744166PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3348898

GET https://conductscience.org/api/papers/v1/3348898/authors